ABM-125 is a human-derived IgG monoclonal antibody targeting IL-25. For the isotype control of ABM-125, refer to HumanIgG1kappa, Isotype Control. It is applicable in research related to viral asthma.
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted